Efavirenz 600mg tabs/PAC-30

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Efavirenz film coated tablets 600mg, pack of 30

Technical Specifications:
Each film coated tablet contains Efavirenz 600mg

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
36 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in adults and children over 3 years of age in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Storage:
Do not store above 30ºC (86ºF), do not freeze.
Store in tightly closed original container
Keep out of reach and sight of children

Dispensing instructions:
Dispense in original container. Do not repack
Advise patient to take the medicine on empty stomach and at bedtime, especially in the first 2-4 weeks to reduce CNS effects.
Note: The dose of Efavirenz oral solution in mg of Efavirenz is not the same as for Efavirenz capsules and tablets.

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items